Lecanemab, sold under the brand name Leqembi, is a monoclonal antibody drug used for the treatment of Alzheimer's disease. Lecanemab is an antibody directed at beta-amyloid. It is administered by intravenous infusion

Manufacturer – Biogen
Specialty – Neurology
Active principle – Lecanemab